Viewing Study NCT01231503


Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2025-12-30 @ 12:12 AM
Study NCT ID: NCT01231503
Status: COMPLETED
Last Update Posted: 2018-08-15
First Post: 2010-10-14
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants
Sponsor: GlaxoSmithKline
Organization: